NCT06871592View on ClinicalTrials.gov

Quantified Evaluation of Whole Face 8-points Supra-periosteum High Molecular Weight Hyaluronic Acid Injection in Asian

Not yet recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

February 27, 2026

Study Completion Date

February 27, 2026

Conditions
Wrinkles
All Listed Sponsors
collaborator

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

lead

Chang Chang Cheng

OTHER

NCT06871592 - Quantified Evaluation of Whole Face 8-points Supra-periosteum High Molecular Weight Hyaluronic Acid Injection in Asian | Biotech Hunter | Biotech Hunter